Elevated Intestinal Fatty Acid Binding Protein and Gastrointestinal Complications Following Cardiopulmonary Bypass: A Preliminary Analysis

Authors: Holmes J.H.1; Lieberman J.M.3; Probert C.B.1; Marks W.H.3; Hill M.E.2; Paull D.L.2; Guyton S.W.2; Sacchettini J.4; Hall R.A.2

Source: Journal of Surgical Research, Volume 100, Number 2, October 2001 , pp. 192-196(5)

Publisher: Academic Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background. Cardiopulmonary bypass (CPB) is associated with poorly understood alterations in gastrointestinal (GI) perfusion. Intestinal fatty acid binding protein (IFABP), a cytosolic protein uniquely located in mature small-intestinal enterocytes, has been shown to be a sensitive biochemical marker of early intestinal ischemia when assayed in urine. We hypothesized that if significant small-intestinal ischemia occurs with CPB, then urine IFABP levels should be concomitantly elevated.

Methods. Twenty-nine patients (15 low risk and 14 high risk) undergoing cardiac surgery with CPB were studied prospectively. Serial urine IFABP levels were measured and results were correlated with clinical outcomes.

Results. None of the low-risk patients had IFABP elevations or experienced GI complications. Five of the high-risk patients had IFABP elevations, and three of the five developed GI complications. Within the high-risk cohort, the only significant difference between patients with or without IFABP elevations was the GI complication rate (P = 0.03). Overall, patients with IFABP elevations had a significantly higher mean ASA class and significant increases in mean CPB and aortic cross-clamp times, mean time to oral intake, median ICU and postoperative lengths of stay, and GI complications.

Conclusions. In low-risk bypass patients, small-bowel mucosal perfusion appeared to be maintained, while in the high-risk population, 21% of the patients sustained clinically significant mucosal compromise. In this pilot study, urine IFABP was 100% sensitive and 92% specific with respect to GI complications. Since elevated urine IFABP concentrations appeared to correlate with clinical GI complications, urine IFABP may be a useful marker to identify the patient at risk for postbypass GI complications. Copyright 2001 Academic Press.

Keywords: cardiopulmonary bypass; gastrointestinal complications; mesenteric ischemia; and intestinal fatty acid binding protein

Language: English

Document Type: Research article

Affiliations: 1: Department of General Surgery 2: Department of General Surgery, Department of Cardiothoracic Surgery, Virginia Mason Medical Center, Seattle, Washington, 98111 3: Department of Organ Transplantation, Swedish Medical Center, Seattle, Washington, 98122 4: Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas, 77843

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$54.13 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A